ELIXIRGEN THERAPEUTICS, INC., 2025-11-13
An SEC Form D private-offering notice from Baltimore, MD, a $4,000,000 filer-stated offering target in Biotech. Filed 2025-11-13. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing gene therapies for rare and aging associated diseases, including a telomere elongation therapy and an mRNA delivery platform for large genetic payloads.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Legends of Learning, Inc., 2025-11-19, $750K, Laurel, MD
- IsoBio, Inc., 2025-11-14, $3M, Gladwyne, PA
- AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC., 2025-11-18, $10M, Rockville, MD
- Carolina Molecular Inc., 2025-11-13, $1.7M, Morrisville, NC
- Cybrary, Inc., 2025-11-17, $4.5M, Riverdale, MD
- Conexeu Sciences Inc., 2025-11-13, $2.9M, Reno, NV
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.